- Report
- July 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- August 2024
- 62 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- August 2024
- 112 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- January 2025
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- August 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- October 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- October 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- December 2024
- 146 Pages
Global
From €3595EUR$3,950USD£3,054GBP
From €3277EUR$3,600USD£2,783GBP
- Report
- October 2024
- 200 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- May 2024
- 140 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- January 2025
- 209 Pages
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- December 2024
Global
From €6826EUR$7,500USD£5,798GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more